메뉴 건너뛰기




Volumn 192, Issue 4, 2005, Pages 705-706

Antimalarial effects of HIV proteinase inhibitors: Common compounds but structurally distinct enzymes [2]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CATHEPSIN D; CATHEPSIN E; PLASMEPSIN II; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

EID: 23244467899     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/432079     Document Type: Letter
Times cited : (6)

References (8)
  • 2
    • 17044432545 scopus 로고    scopus 로고
    • Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors
    • Savarino A, Cauda R, Cassone A. Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors [letter]. J Infect Dis 2005; 191:1381-2.
    • (2005) J Infect Dis , vol.191 , pp. 1381-1382
    • Savarino, A.1    Cauda, R.2    Cassone, A.3
  • 5
    • 0037181136 scopus 로고    scopus 로고
    • Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite Plasmodium falciparum
    • Wyatt D, Berry C. Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite Plasmodium falciparum. FEBS Lett 2002; 513:159-62.
    • (2002) FEBS Lett , vol.513 , pp. 159-162
    • Wyatt, D.1    Berry, C.2
  • 6
    • 0024558304 scopus 로고
    • Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases
    • Richards AD, Roberts R, Dunn BM, Graves MC, Kay J. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases. FEBS Lett 1989; 247:113-7.
    • (1989) FEBS Lett , vol.247 , pp. 113-117
    • Richards, A.D.1    Roberts, R.2    Dunn, B.M.3    Graves, M.C.4    Kay, J.5
  • 7
    • 0028968902 scopus 로고
    • ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability
    • Kempf DJ, Marsh KC, Denissen JF, et al. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability. Proc Natl Acad Sci USA 1995; 92:2484-8.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 2484-2488
    • Kempf, D.J.1    Marsh, K.C.2    Denissen, J.F.3
  • 8
    • 0025268321 scopus 로고
    • Rational design of peptide-based HIV proteinase inhibitors
    • Roberts NA, Martin JA, Kinchington D, et al. Rational design of peptide-based HIV proteinase inhibitors. Science 1990; 248:358-61.
    • (1990) Science , vol.248 , pp. 358-361
    • Roberts, N.A.1    Martin, J.A.2    Kinchington, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.